Apr 19, 2023
US FDA DMF Support for DENARASE® GMP-grade
c-LEcta successfully filed a Drug Master File (Type II) with the US FDA in 2021. We spoke with Dr....
read more
Mar 28, 2023
Kerry and c-LEcta enter agreement to market DENARASE® products
Kerry, a world leader in taste and nutrition, and c-LEcta, a leading biotechnology company in...
read more
Feb 14, 2023
BioProcess International US West, San Diego
From February 27 - March 2, 2023 the BPI US West will take place in San Diego. The BPI US West...
read more
Feb 1, 2023
New sizes of R&D-grade DENARASE® available
c-LEcta has just launched additional sizes of DENARASE®for research and development use. Being...
read more
Aug 31, 2021
Drug Master File for the use of the enzyme DENARASE® in the pharmaceutical industry accepted by the US FDA
c-LEcta has announced the submission of a Master File for its best-selling product DENARASE®. The...
read more